Startseite Remission of hypertension and electrolyte abnormalities following renal transplantation in a patient with apparent mineralocorticoid excess well documented throughout childhood
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Remission of hypertension and electrolyte abnormalities following renal transplantation in a patient with apparent mineralocorticoid excess well documented throughout childhood

  • Ahmed M. Khattab , Cedric H.L. Shackleton , Beverly A. Hughes , Jayesh B. Bodalia und Maria I. New EMAIL logo
Veröffentlicht/Copyright: 14. August 2013

Abstract

Apparent mineralocorticoid excess syndrome (AME) is an autosomal recessive genetic disorder caused by a deficiency in the enzyme 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD). We report a 36-year-old male who was hypertensive from birth and was diagnosed with AME at 8 years of age. There was continuous documentation of his hypertension and hypokalemic alkalosis throughout childhood, during which spironolactone and supplemental potassium were administered. At 33 years of age, the patient received a renal transplant, and following this the AME appears to have been cured clinically with remission of his low renin hypertension and hypokalemic alkalosis despite termination of treatment with spironolactone and potassium supplements.


Corresponding author: Maria I. New, Division of Adrenal Steroid Disorders, Department of Pediatrics, The Mount Sinai School of Medicine, 1249 Fifth Avenue, 4th Floor, Annex 419, New York, NY 10029, USA, Phone: +1212-241-7847, Fax: +1212-241-5405, E-mail: ;

The steroid analysis work was funded by a Wellcome Trust Programme Grant (# 082809) and the European Research Council (#20090506), both awarded to Professor Paul Stewart. Supported in part by USPHS, NIH Division of Research Facilities and Resources, Clinical Research Centers RR 47.

Disclosure summary: The authors have nothing to disclose.

References

1. New MI, Levine LS, Biglieri EG, Pareira J, Ulick S. Evidence for an unidentified steroid in a child with apparent mineralocorticoid hypertension. J Clin Endocrinol Metab 1977;44:924–3310.1210/jcem-44-5-924Suche in Google Scholar

2. Ulick S, Levine LS, Gunczler P, Zanconato G, Ramirez LC, et al. A syndrome of apparent mineralocorticoid excess associated with defects in the peripheral metabolism of cortisol. J Clin Endocrinol Metab 1979;49:757–64.10.1210/jcem-49-5-757Suche in Google Scholar

3. Obeyesekere VR, Ferrari P, Andrews RK, Wilson RC, New MI, et al. The R337C mutation generates a high Km 11 beta-hydroxysteroid dehydrogenase type II enzyme in a family with apparent mineralocorticoid excess. J Clin Endocrinol Metab 1995;80:3381–3.Suche in Google Scholar

4. Wilson RC, Nimkarn S, New MI. Apparent mineralocorticoid excess. Trends Endocrinol Metab 2001;12:104–11.10.1016/S1043-2760(00)00356-8Suche in Google Scholar

5. Dave-Sharma S, Wilson RC, Harbison MD, Newfield R, Azar MR, et al. Examination of genotype and phenotype relationships in 14 patients with apparent mineralocorticoid excess. J Clin Endocrinol Metab 1998;83:2244–54.10.1210/jc.83.7.2244Suche in Google Scholar

6. Palermo M, Shackleton CH, Mantero F, Stewart PM. Urinary free cortisone and the assessment of 11 beta-hydroxysteroid dehydrogenase activity in man. Clin Endocrinol (Oxf) 1996;45:605–11.10.1046/j.1365-2265.1996.00853.xSuche in Google Scholar PubMed

7. Palermo M, Cossu M, Shackleton CH. Cure of apparent mineralocorticoid excess by kidney transplantation (Letter to the editor). N Engl J Med 1998;10;339:1787–8.10.1056/NEJM199812103392414Suche in Google Scholar PubMed

8. Palermo M, Delitala G, Sorba G, Cossu M, Satta R, et al. Does kidney transplantation normalise cortisol metabolism in apparent mineralocorticoid excess syndrome? J Endocrinol Invest 2000;23:457–62.10.1007/BF03343755Suche in Google Scholar PubMed

Received: 2013-6-6
Accepted: 2013-6-18
Published Online: 2013-08-14
Published in Print: 2014-01-01

©2014 by Walter de Gruyter Berlin Boston

Artikel in diesem Heft

  1. Masthead
  2. Masthead
  3. Editorials
  4. Editorial
  5. Consensus, guidelines and reviews
  6. Review article
  7. Adaptation of glucose metabolism to fasting in young children with infectious diseases: a perspective
  8. Images in pediatric endocrinology
  9. Coexistence of testicular microlithiasis with parathyroid adenoma in an obese child
  10. Original articles
  11. Remission of hypertension and electrolyte abnormalities following renal transplantation in a patient with apparent mineralocorticoid excess well documented throughout childhood
  12. Effects of metformin in children and adolescents with Prader-Willi syndrome and early-onset morbid obesity: a pilot study
  13. Glycemic control in familial vs. sporadic type 1 diabetes patients over 5 years
  14. Clinical and laboratory features of temporary brittle bone disease
  15. Age of thelarche and menarche in contemporary US females: a cross-sectional analysis
  16. Teriparatide (rhPTH) treatment in children with syndromic hypoparathyroidism
  17. Retinol and retinyl palmitate in fetal mice liver: sexual dimorphism
  18. Skeletal maturation and predicted adult height in children with premature adrenarche
  19. Homozygosity for a DTDST mutation in a child with multiple epiphyseal dysplasia
  20. Body composition in young patients with galactose metabolic disorders: a preliminary report
  21. Detection of vascular risk markers in children and adolescents with type 1 diabetes
  22. X-linked recessive nephrogenic diabetes insipidus: a clinico-genetic study
  23. Factors influencing neonatal thyroid-stimulating hormone concentrations as a measure of population iodine status
  24. Pediatric idiopathic intracranial hypertension and the underlying endocrine-metabolic dysfunction: a pilot study
  25. Patient reports
  26. Hypothalamic hamartoma associated with central precocious puberty and growth hormone deficiency
  27. A pediatric patient with Cushing syndrome caused by ectopic ACTH syndrome and concomitant pituitary incidentalomas
  28. A novel genetic mutation in a Portuguese family with GCK-MODY
  29. Permanent neonatal diabetes mellitus in monozygotic twins achieving low-dose sulfonylurea therapy
  30. Hypocalcemia in a paediatric case: from the clinical features to diagnosis
  31. A rare case of osteogenesis imperfecta combined with complete tooth loss
  32. Iatrogenic acute pancreatitis due to hypercalcemia in a child with pseudohypoparathyroidism
  33. Clinical expression of familial Williams-Beuren syndrome in a Turkish family
  34. The first report of cabergoline-induced immune hemolytic anemia in an adolescent with prolactinoma
  35. Low-level hyperinsulinism with hypoglycemic spells in an infant with mosaic Turner syndrome and mild Kabuki-like phenotype: a case report and review of the literature
  36. Multiple cutaneous hemangiomas in a patient with combined pituitary hormone deficiency
  37. Premature thelarche related to fennel tea consumption?
  38. A novel insertion in the FOXL2 gene in a Chilean patient with blepharophimosis ptosis epicanthus inversus syndrome type I
  39. Zellweger syndrome: prenatal and postnatal growth failure with epiphyseal stippling
  40. Marine-Lenhart syndrome in a young girl
  41. Novel AQP2 mutation causing congenital nephrogenic diabetes insipidus: challenges in management during infancy
  42. Letter to the Editors
  43. Mutational analysis of KISS1 and KISS1R in idiopathic central precocious puberty
  44. Carotid intima media thickness and echocardiography in risk stratification of obese adolescents with non-alcoholic fatty liver disease: what is the “right” approach?
  45. Vitamin D and the heart: what is the truth?
Heruntergeladen am 24.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jpem-2013-0235/html
Button zum nach oben scrollen